Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system

被引:5
|
作者
Merchenthaler, I [1 ]
Lane, M [1 ]
Shughrue, P [1 ]
机构
[1] Wyeth Ayerst Res, Womens Hlth Res Inst, Radnor, PA 19087 USA
关键词
in situ hybridization; brain mapping; glucagon-like peptide-1 receptor mRNA; ingestive behavior; obesity; pre-pro-glucagon;
D O I
10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glucagon-like peptide-1 (GLP-1) is derived from the peptide precursor pre-pro-glucagon (PPG) by enzymatic cleavage and acts via its receptor, glucagon-like peptide-1 receptor (GLP-1R). By using riboprobes complementary to PPG and GLP-1R, we described the distribution of PPG and GLP-1R messenger RNAs (mRNAs) in the central nervous system of the rat. PPG mRNA-expressing perikarya were restricted to the nucleus of the solitary tact or to the dorsal and ventral medulla and olfactory bulb. GLP-1R mRNA was detected in numerous brain regions, including the mitral cell layer of the olfactory bulb; temporal cortex; caudal hippocampus; lateral septum; amygdala; nucleus accumbens; ventral pallium; nucleus basalis Meynert; bed nucleus of the stria terminalis; preoptic area; paraventricular, supraoptic, arcuate, and dorsomedial nuclei of the hypothalamus; lateral habenula; zona incerta; substantia innominata; posterior thalamic nuclei; ventral tegmental area; dorsal tegmental, posterodorsal tegmental, and interpeduncular nuclei; substantia nigra, central gray; raphe nuclei; parabrachial nuclei; locus ceruleus, nucleus of the solitary tract; area postrema; dorsal nucleus of the vagus; lateral reticular nucleus; and spinal cord. These studies, in addition to describing the sites of GLP-1 and GLP-1R synthesis, suggest that the efferent connections from the nucleus of the solitary tract are more widespread than previously reported. Although the current role of GLP-1 in regulating neuronal physiology is not known, these studies provide detailed information about the sites of GLP-1 synthesis and potential sites of action, an important first step in evaluating the function of GLP-1 in the brain. The widespread distribution of GLP-1R mRNA-containing cells strongly suggests that GLP-1 not only functions as a satiety factor but also stets as a neurotransmitter or neuromodulator in anatomically and functionally distinct areas of the central nervous system. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:261 / 280
页数:20
相关论文
共 50 条
  • [31] Glucagon-Like Peptide-1 and Diabetes
    Monami, Matteo
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [32] Glucagon-like peptide-1 and satiety
    G. van Dijk
    T. E. Thiele
    R. J. Seeley
    S. C. Woods
    I. L. Bernstein
    Nature, 1997, 385 : 214 - 214
  • [33] Glucagon-like peptide-1 and satiety
    van, Dijk, G.
    Thiele, T.E.
    Seeley, R.J.
    Woods, S.C.
    Bernstein, I.L.
    Bloom, S.R.
    Nature, 1997, 385 (6613)
  • [34] Is Glucagon-like peptide-1 for real?
    Murr, Michel M.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2014, 10 (05) : 786 - 786
  • [35] Direct Control of Brown Adipose Tissue Thermogenesis by Central Nervous System Glucagon-Like Peptide-1 Receptor Signaling
    Lockie, Sarah H.
    Heppner, Kristy M.
    Chaudhary, Nilika
    Chabenne, Joseph R.
    Morgan, Donald A.
    Veyrat-Durebex, Christelle
    Ananthakrishnan, Gayathri
    Rohner-Jeanrenaud, Francoise
    Drucker, Daniel J.
    DiMarchi, Richard
    Rahmouni, Kamal
    Oldfield, Brian J.
    Tschoep, Matthias H.
    Perez-Tilve, Diego
    DIABETES, 2012, 61 (11) : 2753 - 2762
  • [36] Can epicardial fat glucagon-like peptide-1 receptor open up to the cardiovascular benefits of glucagon-like peptide-1 analogues?
    Iacobellis, Gianluca
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (03): : 224 - 225
  • [37] Glucagon-Like Peptide-1 Agonists
    Stanton, Eloise W.
    Manasyan, Artur
    Banerjee, Rakhi
    Hong, Kurt
    Koesters, Emma
    Daar, David A.
    ANNALS OF PLASTIC SURGERY, 2025, 94 (01) : 121 - 127
  • [38] Glucagon-like peptide-1 agonists
    Padwal, Raj
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [39] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [40] Differentiation of glucagon and glucagon-like peptide-1 effects on hepatocytes
    Wang, Xiaozhen
    Conway, James
    Beaton, Michelle
    De Los Reyes, Melissa
    Raja, Rajiv
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E552 - E552